Embryo Banking
Embryo Banking
The introduction of Vitrification combined with CGH technology has opened up new possibilities for IVF treatment and fertility preservation. One dilemma that women face when considering IVF at a later age is the fact that they generally have fewer eggs available, and of those, a higher percentage are chromosomally abnormal. A new option that has great promise for halting the biological clock and aiding these women in conception is Embryo Banking. The basic premise is as follows: a woman undergoes 2-3 consecutive IVF stimulation and egg retrieval cycles without an embryo transfer. After each retrieval, the eggs/embryos are biopsied and frozen. When the last egg retrieval is completed, all of the biopsy samples are sent for CGH testing. Once the CGH test results come back and the “competent” eggs/embryos are identified, the woman then schedules her embryo transfer using 1 or 2 of the competent embryos. This optimizes her chances of success, while minimizing the cost of testing and treatment.
- Freeze the Biological Clock
- Multiple Egg Retrievals to Increase Yield
- Competent Embryos Identified by CGH Testing
- Schedule Embryo Transfer to Suit You
Related Posts
Sher Institute Founder, Geoffrey Sher has long been a pioneer in the field and has, along with SIRM colleagues, introduced: 1982: First to recommend the exclusive use of gonadotropins to stimulate follicular development for IVF 1983: First to introduce Intrauterine Insemination (IUI) of washed sperm for treating certain forms of infertility. 1989: First to report … Read more
In the early ’90s, we identified, quantified and published widely on the importance of the pattern and thickness of the uterine lining (endometrium) in determining outcome following in vitro fertilization (IVF). Women in whom the thickness of the endometrium had an abnormal ultrasound pattern and measured less than 9mm around the time of egg retrieval … Read more
Most methods of determining which embryo to transfer to the uterus during In Vitro Fertilization rely on a visual assessment under the microscope. The prettiest embryo wins. Unfortunately, this approach ignores the most common cause of IVF failure – chromosomal abnormalities. Doctors can’t tell by simply looking at an embryo whether it is chromosomally “competent.” … Read more
INTRALIPID 20% – FINALLY AN EFFECTIVE, SAFE AND LOW COST ALTERNATIVE TO IVIG THERAPY SIRM physicians have long advocated aggressive treatment of immunologic implantation dysfunction in women undergoing IVF. In cases where there has been Natural Killer Cell activation (Nka) (as evidenced by an abnormal K562 target cell test) we have championed the use of … Read more
IVF: The SIRM Way A Practical Guide to IVF Treatment This is a detailed overview of the IVF process as practiced at SIRM centers. It incorporates the methods and philosophies that have made SIRM one of the most prominent IVF networks in the world. This book is available for purchase as a pdf file for … Read more
THE EVOLUTION OF CGH EGG AND EMBRYO TESTING AT SIRM Geoffrey Sher MD Three problems have restricted the growth of IVF in the U.S: 1) Cost of service and lack of insurance reimbursement, 2) Ignorance of the fact that IVF is far more efficacious than other infertility treatment and, 3) OB-Gyn’s and/or Reproductive Endocrinologists (RE’s) that … Read more
SIRM-New York is now offering EZ-IVF®, a gentle, low-stimulation form of IVF that is available to ALL patients and offers the following advantages: Low Cost An Option for No Injections Requires No Anesthesia Higher Success Rates than IUI Allows for Genetic Screening CGH/PGD EZ-IVF is also known elsewhere as “minimal stimulation IVF.” The ovaries of a woman are minimally … Read more
Ask Our DoctorsA Question
